Работы, цитирующие эту работу

Работ: 3

Работа: From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   СтатьяCAR-T cell therapy researchClinical & Translational Oncology2026Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.article.000172

2. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

   Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

   СтатьяCAR-T cell therapy researchClinical & Translational Oncology2026Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.article.000259

3. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   СтатьяCancer Immunotherapy and BiomarkersAnnals of Hematology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.009488